BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29130573)

  • 1. Planned angiographic control versus clinical follow-up for patients with unprotected left main stem stenosis treated with second generation drug-eluting stents: A propensity score with matching analysis from the FAILS (failure in left main with second generation stents-Cardiogroup III Study).
    D'Ascenzo F; Iannaccone M; Pavani M; Kawamoto H; Escaned J; Varbella F; Boccuzzi G; Hiddick-Smith D; Colombo A; Gaita F
    Catheter Cardiovasc Interv; 2018 Oct; 92(4):E271-E277. PubMed ID: 29130573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.
    Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of bioresorbable vs durable polymer drug-eluting stents in unprotected left main (from the RAIN-CARDIOGROUP VII Study).
    Iannaccone M; Barbero U; De Benedictis M; Imori Y; Quadri G; Trabattoni D; Ryan N; Venuti G; Montabone A; Wojakowski W; Rognoni A; Helft G; Parma R; De Luca L; Autelli M; Boccuzzi G; Mattesini A; Templin C; Cerrato E; Wańha W; Smolka G; Huczek Z; Tomassini F; Cortese B; Capodanno D; Chieffo A; Nuñez-Gil I; Gili S; Bassignana A; di Mario C; Doronzo B; Omedè P; D'Amico M; Tedeschi D; Varbella F; Luscher T; Sheiban I; Escaned J; Rinaldi M; D'Ascenzo F
    BMC Cardiovasc Disord; 2020 May; 20(1):225. PubMed ID: 32414330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-expandable sirolimus-eluting stents compared to second-generation drug-eluting stents for the treatment of the left main: A propensity score analysis from the SPARTA and the FAILS-2 registries.
    Montefusco A; D'Ascenzo F; Gili S; Smolka G; Chieffo A; Baumbach A; Escaned J; Sganzerla P; Tomassini F; Secco GG; Ugo F; Tamburino C; Nicolino A; Mancone M; Poli A; Yew KL; Cirillo P; Wanha W; Pastormerlo LE; di Summa R; Sardella G; Colombo A; Gaita F; Cortese B
    Catheter Cardiovasc Interv; 2019 Feb; 93(2):208-215. PubMed ID: 30298593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of polymer-free biolimus-eluting stents versus ultrathin stents in unprotected left main or coronary bifurcation: A propensity score analysis from the RAIN and CHANCE registries.
    D'Ascenzo F; Gaido L; Bernardi A; Saglietto A; Franzé A; Ielasi A; Trabattoni D; Di Biasi M; Infantino V; Rognoni A; Helft G; Gangor A; Latini RA; De Luca L; Mitomo S; Ugo F; Smolka G; Huczek Z; Cortese B; Capodanno D; Chieffo A; Piazza F; di Mario C; Poli A; D'Urbano M; Romeo F; Giammaria M; Varbella F; Sheiban I; Escaned J; De Ferrari GM
    Catheter Cardiovasc Interv; 2020 Feb; 95(3):522-529. PubMed ID: 31385427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The DELTA 2 Registry: A Multicenter Registry Evaluating Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents in Patients With Obstructive Left Main Coronary Artery Disease.
    Chieffo A; Tanaka A; Giustino G; Briede I; Sawaya FJ; Daemen J; Kawamoto H; Meliga E; D'Ascenzo F; Cerrato E; Stefanini GG; Capodanno D; Mangiameli A; Templin C; Erglis A; Morice MC; Mehran R; Van Mieghem NM; Nakamura S; De Benedictis M; Pavani M; Varbella F; Pisaniello M; Sharma SK; Tamburino C; Tchetche D; Colombo A;
    JACC Cardiovasc Interv; 2017 Dec; 10(23):2401-2410. PubMed ID: 29217002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of gender on long-term mortality in patients with unprotected left main disease: The Milan and New-Tokyo (MITO) Registry.
    Takagi K; Chieffo A; Shannon J; Naganuma T; Tahara S; Fujino Y; Latib A; Montorfano M; Carlino M; Kawamoto H; Nakamura S; Colombo A
    Cardiovasc Revasc Med; 2016 Sep; 17(6):369-74. PubMed ID: 27460302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 10-month angiographic and 4-year clinical outcome of everolimus-eluting versus sirolimus-eluting coronary stents in patients with diabetes mellitus (the DiabeDES IV randomized angiography trial).
    Maeng M; Baranauskas A; Christiansen EH; Kaltoft A; Holm NR; Krusell LR; Ravkilde J; Tilsted HH; Thayssen P; Jensen LO
    Catheter Cardiovasc Interv; 2015 Dec; 86(7):1161-7. PubMed ID: 25640050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of a combination of full coverage stenting and proximal optimization technique on long term outcome for unprotected distal left main disease.
    Takagi K; Fujino Y; Naganuma T; Watanabe Y; Yabushita H; Mitomo S; Kawamoto H; Tahara S; Kobayashi T; Warisawa T; Karube K; Matsumoto T; Sato T; Ishiguro H; Kurita N; Nakamura S; Hozawa K; Nakamura S
    Cardiovasc Revasc Med; 2016 Dec; 17(8):515-521. PubMed ID: 27720383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials.
    Claessen BE; Smits PC; Kereiakes DJ; Parise H; Fahy M; Kedhi E; Serruys PW; Lansky AJ; Cristea E; Sudhir K; Sood P; Simonton CA; Stone GW
    JACC Cardiovasc Interv; 2011 Nov; 4(11):1209-15. PubMed ID: 22115661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes of percutaneous coronary interventions or coronary artery bypass grafting for left main coronary artery disease in octogenarians (from a Drug-Eluting stent for LefT main Artery registry substudy).
    Conrotto F; Scacciatella P; D'Ascenzo F; Chieffo A; Latib A; Park SJ; Kim YH; Onuma Y; Capranzano P; Jegere S; Makkar R; Palacios I; Buszman P; Chakravarty T; Mehran R; Naber C; Margey R; Leon M; Moses J; Fajadet J; Lefèvre T; Morice MC; Erglis A; Tamburino C; Alfieri O; D'Amico M; Marra S; Serruys PW; Colombo A; Meliga E
    Am J Cardiol; 2014 Jun; 113(12):2007-12. PubMed ID: 24793677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second vs. First generation drug eluting stents in multiple vessel disease and left main stenosis: Two-year follow-up of the observational, prospective, controlled, and multicenter ERACI IV registry.
    Haiek C; Fernández-Pereira C; Santaera O; Mieres J; Rifourcat I; Lloberas J; Larribau M; Pocoví A; Rodriguez-Granillo AM; Sarmiento RA; Antoniucci D; Rodriguez AE
    Catheter Cardiovasc Interv; 2017 Jan; 89(1):37-46. PubMed ID: 26947138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Outcomes of Different Two-Stent Techniques With Second-Generation Drug-Eluting Stents for Unprotected Left Main Bifurcation Disease: Insights From the FAILS-2 Study.
    Pavani M; Conrotto F; Cerrato E; D'Ascenzo F; Kawamoto H; Núñez-Gil IJ; Pennone M; Garbo R; Tomassini F; Colombo F; Scacciatella P; Varbella F; Chieffo A; Colombo A; Escaned J
    J Invasive Cardiol; 2018 Aug; 30(8):276-281. PubMed ID: 30068784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between the NERS (New Risk Stratification) score and the SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) score in outcome prediction for unprotected left main stenting.
    Chen SL; Chen JP; Mintz G; Xu B; Kan J; Ye F; Zhang J; Sun X; Xu Y; Jiang Q; Zhang A; Stone GW
    JACC Cardiovasc Interv; 2010 Jun; 3(6):632-41. PubMed ID: 20630456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of a Simple Angiographic Approach With a Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery Score-Based Approach for Left Main Coronary Artery Stenting: A Pooled Analysis of Serial PRECOMBAT (Premier of Randomized Comparison of Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease) Studies.
    Lee PH; Lee JY; Lee CW; Kim SO; Ahn JM; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Park SJ
    Circ Cardiovasc Interv; 2018 Jan; 11(1):e005374. PubMed ID: 29311287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and Management of Restenosis After Treatment of Unprotected Left Main Disease With Second-Generation Drug-Eluting Stents (from Failure in Left Main Study With 2nd Generation Stents-Cardiogroup III Study).
    D'Ascenzo F; Chieffo A; Cerrato E; Ugo F; Pavani M; Kawamoto H; di Summa R; Varbella F; Boccuzzi G; Omedè P; Rettegno S; Garbo R; Conrotto F; Montefusco A; Biondi-Zoccai G; D'Amico M; Moretti C; Escaned J; Gaita F; Colombo A
    Am J Cardiol; 2017 Apr; 119(7):978-982. PubMed ID: 28131320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Final 5-year outcomes from the Endeavor zotarolimus-eluting stent clinical trial program: comparison of safety and efficacy with first-generation drug-eluting and bare-metal stents.
    Kandzari DE; Leon MB; Meredith I; Fajadet J; Wijns W; Mauri L
    JACC Cardiovasc Interv; 2013 May; 6(5):504-12. PubMed ID: 23602459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiographic and clinical outcome after crush of everolimus-eluting stent for distal unprotected left main disease.
    Migliorini A; Valenti R; Vergara R; Grazia De Gregorio M; Gabrielli E; De Vito E; Raffaella Aicale M; Carrabba N; Antoniucci D
    Catheter Cardiovasc Interv; 2017 Jul; 90(1):72-77. PubMed ID: 28707445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Clinical Outcomes and Optimal Stent Strategy in Left Main Coronary Bifurcation Stenting.
    Cho S; Kang TS; Kim JS; Hong SJ; Shin DH; Ahn CM; Kim BK; Ko YG; Choi D; Song YB; Hahn JY; Choi SH; Gwon HC; Hong MK; Jang Y
    JACC Cardiovasc Interv; 2018 Jul; 11(13):1247-1258. PubMed ID: 29976361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.